UB Paderborn / Katalog / Suche / in CDI

Tumor-associated M2 macrophages in mycosis fungoides acquire immunomodulatory function by interferon alpha and interferon gamma

Journal of dermatological science, 2016-09, Vol.83 (3), p.182-189

2016

Link zum Volltext

Verfügbarkeit prüfen

The possible interaction between periostin expressed by cancer stroma and tumor-associated macrophages in developing mycosis fungoides

Experimental dermatology, 2016-02, Vol.25 (2), p.107-112

2016

Link zum Volltext

Verfügbarkeit prüfen

The Possible Interaction between Receptor Activator of Nuclear Factor Kappa-B Ligand Expressed by Extramammary Paget Cells and its Ligand on Dermal Macrophages

Journal of investigative dermatology, 2015-10, Vol.135 (10), p.2547-2550

2015

Link zum Volltext

Verfügbarkeit prüfen

Epidermal iron metabolism for iron salvage

Journal of dermatological science, 2017-08, Vol.87 (2), p.101-109

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of oral cholecalciferol on rhododendrol‐induced vitiligo: A blinded randomized clinical trial

Journal of dermatology, 2018-04, Vol.45 (4), p.456-462

2018

Link zum Volltext

Verfügbarkeit prüfen

Instrumental evaluation sensitively detects subclinical skin changes by the epidermal growth factor receptor inhibitors and risk factors for severe acneiform eruption

Journal of dermatology, 2019-01, Vol.46 (1), p.18-25

2019

Link zum Volltext

Verfügbarkeit prüfen

Receptor activator of nuclear factor kappa-B ligand (RANKL)/RANK signaling promotes cancer-related inflammation through M2 macrophages

Experimental dermatology, 2016-05, Vol.25 (5), p.397-399

2016

Link zum Volltext

Verfügbarkeit prüfen

Body mass index, HbA1c and serum C‐reactive protein are predictors of secondary failure in infliximab continuance for Japanese psoriasis patients: A hospital‐based retrospective case‐control study

Journal of dermatology, 2021-11, Vol.48 (11), p.1719-1723

2021

Link zum Volltext

Verfügbarkeit prüfen

Cross-sectional survey on disease severity in Japanese patients with harlequin ichthyosis/ichthyosis: Syndromic forms and quality-of-life analysis in a subgroup

Journal of dermatological science, 2018-11, Vol.92 (2), p.127-133

2018

Link zum Volltext

Verfügbarkeit prüfen

Discovery of the First Non-Peptide Full Agonists for the Human Bradykinin B2 Receptor Incorporating 4-(2-Picolyloxy)quinoline and 1-(2-Picolyl)benzimidazole Frameworks

Journal of medicinal chemistry, 2004-05, Vol.47 (11), p.2853-2863

2004

Link zum Volltext

Verfügbarkeit prüfen

A study on the inverse analysis of body force dipole (A proposal of shear type body force dipole for more accurate description of residual stress)

Transactions of the JSME (in Japanese), 2016, Vol.82(837), pp.15-00080-15-00080

2016

Link zum Volltext

Verfügbarkeit prüfen

Plexiform Fibrohistiocytic Tumor on the Ear: Case Report and Immunohistochemical Investigation of Stromal Factor

Case reports in dermatology, 2016-02, Vol.8 (1), p.26-30

2016

Link zum Volltext

Verfügbarkeit prüfen

Alarmin function of cathelicidin antimicrobial peptide LL37 through IL-36γ induction in human epidermal keratinocytes

The Journal of immunology (1950), 2014-11, Vol.193 (10), p.5140-5148

2014

Link zum Volltext

Verfügbarkeit prüfen

Receptor Activator of NF-κB Ligand Promotes the Production of CCL17 from RANK+ M2 Macrophages

Journal of investigative dermatology, 2015-11, Vol.135 (11), p.2884-2887

2015

Link zum Volltext

Verfügbarkeit prüfen

A Novel Class of Orally Active Non-Peptide Bradykinin B2 Receptor Antagonists. 1. Construction of the Basic Framework

Journal of medicinal chemistry, 1998-02, Vol.41 (4), p.564-578

1998

Link zum Volltext

Verfügbarkeit prüfen

Effect of pharmacokinetic profile on the pancreatic toxicity and efficacy of tacrolimus in rats

The Journal of Toxicological Sciences, 2008/12/01, Vol.33(5), pp.575-584

2008

Link zum Volltext

Verfügbarkeit prüfen

A Novel Class of Orally Active Non-Peptide Bradykinin B2 Receptor Antagonists. 3. Discovering Bioisosteres of the Imidazo[1,2-a]pyridine Moiety

Journal of medicinal chemistry, 1998-10, Vol.41 (21), p.4062-4079

1998

Link zum Volltext

Verfügbarkeit prüfen

Study on the Inverse Analysis of Body Force Dipole Distribution Using Surface Stresses

Journal of Computational Science and Technology, 2009, Vol.3(1), pp.115-123

2009

Link zum Volltext

Verfügbarkeit prüfen

The identification of an orally active, nonpeptide bradykinin B2 receptor antagonist, FR173657

British journal of pharmacology, 1997-02, Vol.120 (4), p.617-624

1997

Link zum Volltext

Verfügbarkeit prüfen

The identification of an orally active, nonpeptide bradykinin B 2 receptor antagonist, FR173657

British journal of pharmacology, 2009-02, Vol.120 (4), p.617-624

2009

Link zum Volltext

Verfügbarkeit prüfen

A Study on the Inverse Analysis of Body Force Dipole Distribution Using Surface Stresses: 1st Report, Dimensional Basic Solutions of a Body Force Dipole

Transactions of the Japan Society of Mechanical Engineers Series A, 2007/11/25, Vol.73(735), pp.1230-1235

2007

Link zum Volltext

Verfügbarkeit prüfen

A Novel Class of Orally Active Non-Peptide Bradykinin B2 Receptor Antagonists. 4. Discovery of Novel Frameworks Mimicking the Active Conformation

Journal of medicinal chemistry, 1998-11, Vol.41 (23), p.4587-4598

1998

Link zum Volltext

Verfügbarkeit prüfen

A Novel Class of Orally Active Non-Peptide Bradykinin B2 Receptor Antagonists. 2. Overcoming the Species Difference between Guinea Pig and Man

Journal of medicinal chemistry, 1998-10, Vol.41 (21), p.4053-4061

1998

Link zum Volltext

Verfügbarkeit prüfen

Receptor Activator of NF-[kappa]B Ligand Promotes the Production of CCL17 from RANK+ M2 Macrophages

Journal of investigative dermatology, 2015-11, Vol.135 (11), p.2884

2015

Link zum Volltext

Verfügbarkeit prüfen

Novel Subtype-Selective Nonpeptide Bradykinin Receptor Antagonists FR167344 and FR173657

Molecular pharmacology, 1997-02, Vol.51 (2), p.171-176

1997

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Tumor-associated M2 macrophages in mycosis fungoides acquire immunomodulatory function by interferon alpha and interferon gamma

The possible interaction between periostin expressed by cancer stroma and tumor-associated macrophages in developing mycosis fungoides

The Possible Interaction between Receptor Activator of Nuclear Factor Kappa-B Ligand Expressed by Extramammary Paget Cells and its Ligand on Dermal Macrophages

Epidermal iron metabolism for iron salvage

Efficacy of oral cholecalciferol on rhododendrol‐induced vitiligo: A blinded randomized clinical trial

Instrumental evaluation sensitively detects subclinical skin changes by the epidermal growth factor receptor inhibitors and risk factors for severe acneiform eruption

Receptor activator of nuclear factor kappa-B ligand (RANKL)/RANK signaling promotes cancer-related inflammation through M2 macrophages

Body mass index, HbA1c and serum C‐reactive protein are predictors of secondary failure in infliximab continuance for Japanese psoriasis patients: A hospital‐based retrospective case‐control study

Cross-sectional survey on disease severity in Japanese patients with harlequin ichthyosis/ichthyosis: Syndromic forms and quality-of-life analysis in a subgroup

Discovery of the First Non-Peptide Full Agonists for the Human Bradykinin B2 Receptor Incorporating 4-(2-Picolyloxy)quinoline and 1-(2-Picolyl)benzimidazole Frameworks

A study on the inverse analysis of body force dipole (A proposal of shear type body force dipole for more accurate description of residual stress)

Plexiform Fibrohistiocytic Tumor on the Ear: Case Report and Immunohistochemical Investigation of Stromal Factor

Alarmin function of cathelicidin antimicrobial peptide LL37 through IL-36γ induction in human epidermal keratinocytes

Receptor Activator of NF-κB Ligand Promotes the Production of CCL17 from RANK+ M2 Macrophages

A Novel Class of Orally Active Non-Peptide Bradykinin B2 Receptor Antagonists. 1. Construction of the Basic Framework

Effect of pharmacokinetic profile on the pancreatic toxicity and efficacy of tacrolimus in rats

A Novel Class of Orally Active Non-Peptide Bradykinin B2 Receptor Antagonists. 3. Discovering Bioisosteres of the Imidazo[1,2-a]pyridine Moiety

Study on the Inverse Analysis of Body Force Dipole Distribution Using Surface Stresses

The identification of an orally active, nonpeptide bradykinin B2 receptor antagonist, FR173657

The identification of an orally active, nonpeptide bradykinin B 2 receptor antagonist, FR173657

A Study on the Inverse Analysis of Body Force Dipole Distribution Using Surface Stresses: 1st Report, Dimensional Basic Solutions of a Body Force Dipole

A Novel Class of Orally Active Non-Peptide Bradykinin B2 Receptor Antagonists. 4. Discovery of Novel Frameworks Mimicking the Active Conformation

A Novel Class of Orally Active Non-Peptide Bradykinin B2 Receptor Antagonists. 2. Overcoming the Species Difference between Guinea Pig and Man

Receptor Activator of NF-[kappa]B Ligand Promotes the Production of CCL17 from RANK+ M2 Macrophages

Novel Subtype-Selective Nonpeptide Bradykinin Receptor Antagonists FR167344 and FR173657

Suchergebnisse filtern